Huons Approves Small-Scale Merger of Subsidiary Huons Life Science Without Issuing New Shares; Opposition Only 0.5%
Huons decided to absorb its wholly-owned subsidiary Huons Life Science through a merger without issuing new shares
Merger ratio 1.0000000 : 0.0000000, no new shares issued (no dilution)
Opposition shares are 59,403 (0.5% of total outstanding), meeting the threshold for small-scale merger; board approval substitutes for shareholder meeting
Effective date: June 23, 2026
No appraisal rights granted
KOSDAQ Filing Information
Filing: Other Management Matters (Voluntary Disclosure) - Report on Result of Board Resolution Approving Small-Scale Merger (In Lieu of Shareholders' Meeting)